🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/02/2023 | 251,04 | 256,80 | 248,42 | 255,76 | +1,71% | 3,34% | 589.400 |
| 16/02/2023 | 253,85 | 254,73 | 248,05 | 251,45 | -0,75% | 2,63% | 457.000 |
| 15/02/2023 | 252,70 | 254,72 | 250,55 | 253,36 | +0,09% | 1,65% | 414.700 |
| 14/02/2023 | 255,27 | 259,17 | 252,67 | 253,14 | -1,12% | 2,55% | 428.400 |
| 13/02/2023 | 253,59 | 256,33 | 253,17 | 256,00 | +0,35% | 1,25% | 235.900 |
| 10/02/2023 | 254,74 | 257,07 | 251,90 | 255,11 | +0,74% | 2,03% | 483.000 |
| 09/02/2023 | 253,38 | 255,95 | 252,01 | 253,24 | +0,19% | 1,55% | 432.600 |
| 08/02/2023 | 255,47 | 255,47 | 251,59 | 252,77 | -1,13% | 1,52% | 220.800 |
| 07/02/2023 | 254,09 | 255,86 | 251,02 | 255,65 | +0,16% | 1,90% | 312.100 |
| 06/02/2023 | 252,80 | 260,69 | 252,25 | 255,24 | +0,97% | 3,34% | 423.600 |
| 03/02/2023 | 259,23 | 262,77 | 252,30 | 252,80 | -2,57% | 4,04% | 500.700 |
| 02/02/2023 | 259,52 | 259,86 | 253,03 | 259,48 | -0,20% | 2,63% | 431.200 |
| 01/02/2023 | 261,33 | 262,32 | 258,52 | 259,99 | -1,21% | 1,45% | 367.500 |
| 31/01/2023 | 259,62 | 263,73 | 259,62 | 263,17 | +1,72% | 1,58% | 329.300 |
| 30/01/2023 | 259,97 | 260,98 | 256,63 | 258,71 | -0,37% | 1,67% | 211.800 |
| 27/01/2023 | 263,50 | 263,97 | 258,17 | 259,68 | -1,72% | 2,20% | 218.000 |
| 26/01/2023 | 266,00 | 266,00 | 262,81 | 264,23 | -0,64% | 1,20% | 246.700 |
| 25/01/2023 | 260,75 | 266,05 | 255,52 | 265,92 | +2,11% | 4,04% | 360.600 |
| 24/01/2023 | 260,10 | 260,82 | 257,02 | 260,42 | +0,61% | 1,46% | 196.400 |
| 23/01/2023 | 261,50 | 262,03 | 257,13 | 258,84 | -1,09% | 1,87% | 269.600 |
| 20/01/2023 | 260,67 | 262,85 | 258,43 | 261,70 | +0,65% | 1,70% | 358.700 |
| 19/01/2023 | 261,01 | 261,73 | 258,15 | 260,02 | +0,18% | 1,37% | 293.200 |
| 18/01/2023 | 261,20 | 263,25 | 258,38 | 259,56 | -0,59% | 1,86% | 286.200 |
| 17/01/2023 | 261,00 | 263,67 | 259,24 | 261,10 | +0,02% | 1,70% | 341.600 |
| 13/01/2023 | 261,70 | 264,58 | 259,47 | 261,04 | -0,20% | 1,95% | 350.800 |
| 12/01/2023 | 259,82 | 264,32 | 258,56 | 261,56 | -0,85% | 2,22% | 277.600 |
| 11/01/2023 | 265,15 | 265,15 | 257,88 | 263,79 | +0,14% | 2,74% | 383.500 |
| 10/01/2023 | 264,95 | 266,60 | 261,08 | 263,41 | -0,59% | 2,08% | 599.700 |
| 09/01/2023 | 275,47 | 275,97 | 263,41 | 264,97 | -4,06% | 4,56% | 492.700 |
| 06/01/2023 | 274,95 | 279,14 | 272,94 | 276,17 | +0,75% | 2,25% | 341.600 |